Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma.
Joun GL, Kempe EG, Chen B, Sterling JR, Abbassi RH, Friess D, Singleton M, Choudhury C, Marian OC, du Preez WD, Recasens A, Clark T, Du TY, Low JKK, Kim H, Yang P, Khor J, Hoque M, Indurthi DC, Kuchibhotla M, Palanisamy R, Jorgensen WT, Montgomery AP, Baker JR, Higginbottom SL, Tomaskovic-Crook E, Crook JM, Loo L, Day BW, Neely GG, Guccione E, Johns TG, Kassiou M, Feng Y, Harris L, Don AS, Munoz L.
Joun GL, et al. Among authors: clark t.
Nat Commun. 2025 Dec 15;16(1):10905. doi: 10.1038/s41467-025-65888-5.
Nat Commun. 2025.
PMID: 41397959
Free PMC article.